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EXERCISE CAPACITY AND NEUROENDOCRINE R SPONSE IN FOUR A NEW LOW THRES 
PACING WODES - WZTHiN PATIENT COMPARISON ELECTRODE: IRIT 
m MRCP, Heurig Williams WRCP, Rafique 
Ahmed RD, Ann Ingram, Stafford Lightman FRCP, Richard 
Sutton DScMed FACC. Westminster Hospital, London, UK. 
5 patients with complete atrioventriculer block received 
a dual chamber pacemaker with dynamic A-V delay (Paragon, 
Pacesetter). 4 exercise tests were performed in modes 
WI, WIR, DDD and DDD+AV in which the A-V delay shortens 
at faster rates. Blood for plasma atria1 natriuretic 
peptide (ANP), plasma renin activity (PRA) and arginine 
vasopressin (AVP) was drawn at rest and after a period 
of exercise equivalent to the peak achievement in WI 
(“peak WI”) . The init!.al mode was WI to establish the 
exercise time frame, the other modes were randomised and 
double-blind. WIR was imposed by use of an external 
ACtiVitraX. 
Made Duration Rest ANP Peak ANP 
Onin) (PmWl) (pmol/l) 
WI 11.0*1.0* 102+,33 179+,39** 
WIR 12.2*1.0 80&15 115f16*** 
DDD 12.5kl.O 2925 71518 
DDD+AV 13.Okl.O 42$14 66&20 
f# ~~0.05 vs WIR, DDD and DDD+AV 
*a ~~0.05 vs DDD and DDDtAV 
*** ~~0.05 vs DOD and DDDtAV 
No significant change in PRA or AVP. 
Conclusions: WIR, DDD and DDD+AV resulted in 
significantly longer exercise duration than WI. Lower 
levels of ANP at equivalent amount of exercise (= peak 
WI) is consistent with improved haemodynamics in WIR, 
DDD and DDDtAV, when compared with WI. Levels of AM 
at “peak WI” are lower in both DDD and DDDtAV compared 
with WIR but there is no difference between DDD and 
DDMAV. 
Hichigan; Wayne State Unioereity, Detroit, 
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Comparative chronic mean thld/l: eem showed 
siguifjcantly lower valuea for the new Pl-P th 
3mo 
.07/.04 .10/.006 .lO/.OOl 
691TA-35T .lO/.Of .18/.17 
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(*p < .05 compared to model 4951P E) 
Conclusion: The Pl-P E desigra li 
improves epi paciw capabilities 
THE IMPACT OF STEROID EIBTING 
IN THE ATRIUM AND VENTRICLE 
LEADS ON LONG TERM PACING 
, 
Hospital, London, UK. 
Sema Guneri MD. Westminster 
129 right ventricular (Redtronic‘ (ND) Zr.9) and 115 
right atria1 (MD 4503) steroid eluting leads have been 
implanted 1983-S. Complisations: 1 displacement of MD 
4503 (0.90), nil else;. 73 MD 4003 and 51 HO 4503 were 
selected for comI;;~son wLth 73 HD 4011 and 41 MD 4511 
non-steroid eluting leads, the basis of 
programmability of the impianted g%erators (Pacesetter 
233/255, Biotronik 04/05, WD 7005) offering data on P/R 
amplitude and stimulation threshold. Implant data was 
measured an MD 5309/5311. No significant difference in 
any psraweters was detected between steroid and non- 
steroid leads at implant. Both short (one week) and long 
term (b-10 months) atria1 thresholds were improved 
1.10&0.55 vs 1.6520.94 V (~~0.01) and 0.92kO.04 vs 
1.07kO.28 V (peO.001) respectively (data given for 
Pacesetter units). Medium term (Qne month) ventricular 
thresholds were also improved G.91AO.07 vs 1.19&0.47 V
(PCO.01). Short and medium term P wave amplitude was 
improved 2.36kl.63 vs 1.71+,0.86mV (~~0.05) and 3.16k2.16 
vs 1.97+0.97 mV (~~0.05) respectively and long term R 
wave amplitude was improved 10.0&1.91 vs 8.6122.85 mV 
(pc3.01) . In 92 atria1 leads existence of sinus node 
disease did not influence P wave amplitude. 
conclusion steroid eluting leads offer possibility zi 
safe long term pacing at 2.5 V output or even lOWeE and 
better sensing characteristics inboth chambers 
